Results 101 to 110 of about 52,371 (280)

Outcomes of refractory and early‐relapsed large B‐cell lymphoma patients after first‐line treatment in the prospective Real‐world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre‐CAR T era

British Journal of Haematology, EarlyView.
Stéphanie Guidez, Aurélien Belot, Fanny Cherblanc, Bastien Lesné, Sylvain Carras, Catherine Thieblemont, Fontanet Bijou, Cédric Rossi, Luc Mathieu Fornecker, Jehan Dupuis, Krimo Bouabdallah, Ludovic Fouillet, Adrien Chauchet, Benoit Tessoulin, Loic Ysebaert, Alice Pauc, Pascale Cony‐Makhoul, Remy Gressin, Gaelle Laboure, Antoine Bonnet, Sandy Amorim, Christophe Fruchart, Roch Houot, Gian Matteo Pica, Carole Soussain, Sophie Dennetiere, Cécile Leyronnas, Pauline Lionne‐Huyghe, Hervé Ghesquières, Pierre Sesques   +29 more
wiley   +1 more source

Aberrant Expression of Multiple T‐Cell Markers in Primary Cutaneous Follicle Center Lymphoma: A Rare Case Report

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Aberrant expression of T‐cell markers in B‐cell lymphomas is rare and can pose diagnostic challenges. We report a case of a 65‐year‐old man presenting with newly developed scalp nodules. Histopathology revealed nodular lymphoid infiltrates composed of large centrocytes and centroblasts.
V. Pfefferle, A. Vogelsberg, M. Maaß, C. M. Schürch, S. Forchhammer   +4 more
wiley   +1 more source

Bullous Eruption Associated With Loncastuximab Tesirine in a Patient With Diffuse Large B‐Cell Lymphoma

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Loncastuximab tesirine (LT) is an antibody‐drug conjugate (ADC), a novel class of therapeutics that combines a target‐specific monoclonal antibody with a cytotoxic agent via a chemical linker. LT has been approved in the United States as therapy for relapsed or refractory diffuse large B‐cell lymphoma (DLBCL).
Daniella Jaguan, Cuong Nguyen, Jennifer N. Choi   +2 more
wiley   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

European Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto, Silvia Sorella, Erminia Baldacci, Massimo Breccia, Sabina Chiaretti, Marcello Capriata, Livia Donzelli, Gianna Maria D'Elia, Salvatore Giacomo Morano, Ilaria Del Giudice, Maurizio Martelli, Cristina Santoro, Antonio Chistolini   +12 more
wiley   +1 more source

Simultaneous Presentation of Follicular Lymphoma and Diffuse Large B-cell lymphoma (DLBCL): A Case Report

Indonesian Journal of Cancer
Introduction: The natural history of follicular lymphoma (FL) is frequently characterized by transformation to a more aggressive diffuse large B-cell lymphoma (DLBCL).
Rosmeri Handayani, Agus Susanto Kosasih
doaj   +1 more source

The Baseline Molecular Profile of Late Relapse: Identifying Drivers of Delayed Recurrence in DLBCL [PDF]

Hematol Oncol
Hematological Oncology, Volume 44, Issue 6, November 2026.
Masar M, Novak J, Walker J, Vodicka P, Dropik A, Xianyu Z, Maurer M, Habermann T, Mou E, King R, Wenzl K, Witzig T, Ansell S, Klener P, Cerhan J, Trneny M, Wang Y, Klanova M, Novak A.   +18 more
europepmc   +2 more sources

Improving on R-ICE in relapsed DLBCL [PDF]

Blood, 2018
In this issue of Blood, Sauter et al report the results of a multicenter phase 1 study of rituximab, ifosfamide, carboplatin, and etoposide (R-ICE) in combination with ibrutinib in relapsed/refractory diffuse large B-cell lymphoma.1 This combination was well tolerated and resulted in high response rates.
openaire   +2 more sources

Patient characteristics at diagnosis of EBV+ DLBCL (11 cases).

, 2018
Patient characteristics at diagnosis of EBV+ DLBCL (11 cases).
Xiaoge Zhou (5628638), Gang Chen (107840), Huilan Rao (3202530), Qing Liu (20889), Zhe Wang (41178), Hualiang Xiao (5628641), Shigeo Nakamura (283910), Weihua Yin (5628644), Fang Liu (13271)   +8 more
core   +1 more source

Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non‐Hodgkin Lymphoma on Reproduction Patterns

European Journal of Haematology, EarlyView.
ABSTRACT Concerns about treatment‐related fertility impairment are common among young adult lymphoma survivors. Evidence on the impact of treatment for aggressive non‐Hodgkin lymphoma (NHL) on future childbearing is limited, although many individuals of reproductive age are affected.
Stefanie Antonilli, Anna Marklund, Joshua Entrop, Caroline E. Dietrich, Ingrid Glimelius, Tarec C. El‐Galaly, Alexander Fosså, Harald Holte, Karin E. Smedby, Knut B. Smeland, Sandra Eloranta   +10 more
wiley   +1 more source

Clinical characteristics and histopathologic features of AR-DLBCL cases.

, 2017
Clinical characteristics and histopathologic features of AR-DLBCL cases.
George A. Jones (3743452), Erin G. Reid (453781), Sara H. Browne (3743455), Julio A. Diaz-Perez (3743461), Charles C. King (156152), Michael Preziosi (3743458), Sonia Jain (227879), Huan-You Wang (129843), Scott VandenBerg (3743449), Xiaoying Sun (2505013)   +9 more
core   +1 more source